The Antibody Response to the HIV-1 Specific "out" (vpu) Protein: Identification of an Immunodominant Epitope and Correlation of Antibody Detectability to Clinical Stages
Overview
Affiliations
Overlapping decapeptides based on the sequences of two human immunodeficiency virus type 1 (HIV-1) strains (HXB2 and ELI) were used to identify an immunodominant epitope of the nonstructural protein "out" (vpu) of the human immunodeficiency virus type 1. Of 29 HIV-1 antibody-positive sera, 6 reacted with decapeptides corresponding to the C-terminal amino acid sequence VEMGVEMGHHAPWDVDDL of the "out" (vpu) protein. This oligopeptide was synthesized by the solid phase method and used to develop an enzyme-linked immunosorbent assay (ELISA) for screening of 243 HIV-1-seropositive and 75 HIV-1-seronegative sera. It was found that 26% of the HIV-1 antibody-positive sera were reactive in the "out" (vpu) peptide ELISA, whereas none of the HIV-1-negative sera reacted with the oligopeptide. Correlation of reactivity of sera with the Walter Reed (WR) staging classification demonstrated that individuals classified WR 1 (36%) and WR 2 (42%) were more often reactive than patients classified WR 3-6 (11%).
Peptide design by artificial neural networks and computer-based evolutionary search.
Schneider G, Schrodl W, Wallukat G, Muller J, Nissen E, Ronspeck W Proc Natl Acad Sci U S A. 1998; 95(21):12179-84.
PMID: 9770460 PMC: 22805. DOI: 10.1073/pnas.95.21.12179.
Schubert U, Strebel K J Virol. 1994; 68(4):2260-71.
PMID: 8139011 PMC: 236702. DOI: 10.1128/JVI.68.4.2260-2271.1994.
Bour S, Schubert U, Strebel K J Virol. 1995; 69(3):1510-20.
PMID: 7853484 PMC: 188742. DOI: 10.1128/JVI.69.3.1510-1520.1995.
Serological markers as prognostic criteria for the course of HIV infection.
Kleinschmidt A, Matuschke A, Goebel F, Erfle V, Hehlmann R Infection. 1991; 19 Suppl 2:S89-92.
PMID: 1901833 DOI: 10.1007/BF01644474.
Schneider T, Hildebrandt P, Rokos K, Schubert U, Ronspeck W, Grund C Arch Virol. 1992; 125(1-4):161-76.
PMID: 1642549 DOI: 10.1007/BF01309635.